Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.

Saved in:
Bibliographic Details
Title: Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.
Authors: Rendeiro AF; Institute of Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA., Casano J; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Vorkas CK; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Singh H; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Morales A; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., DeSimone RA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Ellsworth GB; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Soave R; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Kapadia SN; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Saito K; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Brown CD; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Hsu J; Division of Hematology/Oncology, Department of Medicine Weill Cornell Medicine, New York, NY, USA., Kyriakides C; Department of Rehabilitation Medicine at New York University Grossman School of Medicine New York, NY, USA., Chiu S; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Cappelli LV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Cacciapuoti MT; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Tam W; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Galluzzi L; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, New York, NY, USA.; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Simonson PD; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Elemento O; Institute of Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA ole2001@med.cornell.edu.; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA., Salvatore M; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA mis2053@med.cornell.edu.; Division of Public Health Programs, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA ggi9001@med.cornell.edu.
Source: Life science alliance [Life Sci Alliance] 2020 Dec 24; Vol. 4 (2). Date of Electronic Publication: 2020 Dec 24 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Life Science Alliance, LLC Country of Publication: United States NLM ID: 101728869 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2575-1077 (Electronic) Linking ISSN: 25751077 NLM ISO Abbreviation: Life Sci Alliance Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2575-1077
DOI:10.26508/lsa.202000955